Paper Details

  1. Home
  2. Paper Details

Cognitive side-effects of phenytoin compared with carbamazepine in patients with localization-related epilepsy.

Author: AldenkampA P, AlphertsW C, DiepmanL, OverwegJ, VermeulenJ, van 't SlotB

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Controlled Clinical TrialA clinical trial that evaluates the effectiveness of a treatment by comparing a group that receives the intervention with a group that receives a placebo or standard treatment.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

The study compared the cognitive side effects of carbamazepine and phenytoin in patients with epilepsy. Phenytoin was found to be associated with a greater impact on motor speed and mental speed compared to carbamazepine. No significant differences were found in other cognitive domains, such as memory and attention.
Paper Details　
Original Abstract of the Article :
In continuation of an earlier study of our group (Neurology, 43 (1) (1993) 41-51), we present the results of an investigation of the adverse effects of carbamazepine versus phenytoin on cognitive function. Two groups of twenty-five patients are compared in an open, parallel group and non-randomized ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/0920-1211(94)90086-8

データ提供：米国国立医学図書館（NLM）

Cognitive Effects of Antiepileptic Drugs: A Tale of Two Medications

Navigating the challenging landscape of epilepsy treatment, researchers are constantly seeking the optimal balance between seizure control and minimal side effects. This study, published in [journal name], delves into the cognitive impact of two commonly prescribed antiepileptic drugs, carbamazepine (CBZ) and phenytoin (PHT). The study, like a desert explorer charting a new course, compares the cognitive performance of two groups of patients, each receiving monotherapy with one of the drugs.

Phenytoin's Impact on Cognitive Speed: A Slowing Down Effect

The findings reveal a significant difference in cognitive speed between the two groups. The phenytoin group displayed slower performance on all tests measuring motor speed. Moreover, the study suggests that PHT may hinder the speed of central processing systems. This is like observing the slow, deliberate pace of a camel traversing the desert, compared to the swiftness of a gazelle. These findings, like a beacon in the desert, emphasize the potential cognitive side effects associated with phenytoin treatment, even within the therapeutic range.

Navigating Cognitive Side Effects: Staying Alert

The study's findings highlight the importance of ongoing monitoring and careful consideration of potential cognitive side effects in patients receiving phenytoin treatment. The desert of epilepsy treatment requires vigilance, and understanding the potential impact of medication on cognitive function is paramount. Regular cognitive evaluations, like strategically placed oases, can help ensure optimal patient care.

Dr.Camel's Conclusion

The study reveals the intricate relationship between medication and cognitive function, reminding us that the desert of epilepsy treatment requires careful navigation. Understanding the potential impact of medications, like identifying hidden springs in the desert, can help optimize treatment strategies and improve patient outcomes. Continued research and monitoring are crucial to ensuring that patients experience both seizure control and cognitive well-being.

Date :
  1. Date Completed 1995-02-08
  2. Date Revised 2019-09-13
Further Info :

Pubmed ID

7813412

DOI: Digital Object Identifier

10.1016/0920-1211(94)90086-8

Related Literature

Article Analysis
・Side Effects of carbamazepine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.